Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

CJC-1295 No DAC | ≥99% Pure

CJC-1295 (without DAC) Peptide $39.00 – $86.00Price range: $39.00 through $86.00 Select options CJC-1295 (without DAC) Peptide Price range: $39.00 through $86.00 High-purity CJC-1295 without DAC is designed for advanced GHRH receptor and pulsatile growth hormone research. CJC-1295 without DAC (modified GRF 1-29), a tetrasubstituted GHRH analog, is widely utilized in scientific studies exploring short-acting pituitary stimulation, synergistic GH dynamics, and somatotropic axis mechanisms in pre-clinical models. For Research Use Only. Not for human use. Description Additional information Peptide Research Storage & Handling CJC-1295 without DAC is a synthetic GHRH analog extensively used in preclinical research to investigate time-limited receptor activation, cAMP-mediated GH secretion, and natural-like pulsatile release patterns. This research-grade peptide is produced under stringent GMP-compliant conditions and provided as a lyophilized powder to ensure superior purity, stability, and

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

CJC-1295 (without DAC) Peptide

$39.00 – $86.00Price range: $39.00 through $86.00 Select options

CJC-1295 (without DAC) Peptide

Price range: $39.00 through $86.00

High-purity CJC-1295 without DAC is designed for advanced GHRH receptor and pulsatile growth hormone research. CJC-1295 without DAC (modified GRF 1-29), a tetrasubstituted GHRH analog, is widely utilized in scientific studies exploring short-acting pituitary stimulation, synergistic GH dynamics, and somatotropic axis mechanisms in pre-clinical models. For Research Use Only. Not for human use.

Description Additional information Peptide Research Storage & Handling

CJC-1295 without DAC is a synthetic GHRH analog extensively used in preclinical research to investigate time-limited receptor activation, cAMP-mediated GH secretion, and natural-like pulsatile release patterns. This research-grade peptide is produced under stringent GMP-compliant conditions and provided as a lyophilized powder to ensure superior purity, stability, and reliability in experimental applications. For Research Use Only. Not for human use.

Engineered solely for preclinical investigations, each batch of CJC-1295 without DAC undergoes a comprehensive quality assessment and includes complete documentation, including a Certificate of Analysis (COA), purity data, and structural verification. As described in peer-reviewed literature, CJC-1295 without DAC is a synthetic analog of growth hormone-releasing hormone (GHRH) studied for its role in pulsatile GH secretion dynamics in laboratory models (academic.oup.com).

Scientific Overview

CJC-1295 without DAC binds to GHRH receptors, stimulating pituitary somatotrophs, and exhibits a short half-life in research settings. Preclinical investigations examine CJC-1295 without DAC in the following in vitro and in vivo laboratory contexts:

Transient GH release via adenylyl cyclase and cAMP elevation in pituitary models Synergistic amplification of GH pulses when combined with GHRP compounds in rodent models Maintenance of somatostatin-mediated negative feedback in acute laboratory protocols IGF-1 axis modulation studies in controlled preclinical settings Short-term endocrine signaling investigations in experimental models

Research-Referenced Functional Attributes (Based on existing preclinical and literature data — not intended as claims of therapeutic use)

Activation of GHRH receptors leading to time-limited GH secretion in pituitary cell cultures (DOI: 10.1210/en.2005-0664 related GRF analogs) Synergistic GH release with GHRP compounds in rodent models (DOI: 10.1210/jc.2004-1719) Preservation of natural pulsatile patterns and feedback inhibition in acute administration studies Support for investigations into short-acting somatotropic signaling without sustained exposure Examination of IGF-1 responses in controlled preclinical protocols Examination of receptor desensitization dynamics in short-duration laboratory models

Why Researchers Choose Our CJC-1295 without DAC

For laboratories requiring dependable CJC-1295 without DAC research peptide, our manufacturing process prioritizes reproducibility and scientific precision. Every batch is confirmed for:

Purity ≥99% by HPLC Structural identity via mass spectrometry Third-party Certificate of Analysis (COA) available per lot

For Research Use Only. Not for human use. This product is a research chemical intended solely for laboratory and preclinical research purposes. It is not intended for administration to humans or animals.

Additional information

Weight .125 lbs Dimensions 9 × 7 × .5 in Size: No selection

5mg, 10mg

Peptide Research

Sikiric P et al. (2020) BPC-157 tendon healing [PMID: 32083527, https://pubmed.ncbi.nlm.nih.gov/32083527/]. Goldstein AL et al. (2007) Thymosin beta-4 wound healing [PMID: 17541284, https://pubmed.ncbi.nlm.nih.gov/17541284/]. Philp D et al. (2003) TB-500 dermal repair [PMID: 12690326, https://pubmed.ncbi.nlm.nih.gov/12690326/]. Wang Y et al. (2023) TB-500 musculoskeletal injury [DOI: 10.1016/j.jor.2023.05.012, https://www.sciencedirect.com/science/article/pii/S0972978X23000512]. Revolution Health (2025) BPC-157/TB-500 synergy [https://revolutionhealth.org/blogs/news/bpc-157-tb-500-combination-peptide]. Poseidon Performance (2025) BPC-157/TB-500 comparison [https://www.poseidonperformance.com/blog/bpc-157-and-tb-500-the-truth-about-healing-peptides-dosage-and-risks].

Keep lyophilized peptides sealed in their original vial, protected from light and humidity, and store at -4°F or colder for optimal long-term stability in research settings; short-term refrigeration at around 39°F suffices for immediate use within weeks, though freezer storage maximizes integrity across extended research timelines.

Connected topics

Follow this recovery question